View Item 

Show simple item record

Outcomes of Sacral Neuromodulation in a Privately Insured Population
dc.contributor.authorAnger, Jennifer T.
dc.contributor.authorCameron, Anne P.
dc.contributor.authorMadison, Rodger
dc.contributor.authorSaigal, Christopher
dc.contributor.authorClemens, J. Quentin
dc.date.accessioned2016-10-17T21:19:06Z
dc.date.available2017-12-01T21:54:12Zen
dc.date.issued2016-10
dc.identifier.citationAnger, Jennifer T.; Cameron, Anne P.; Madison, Rodger; Saigal, Christopher; Clemens, J. Quentin (2016). "Outcomes of Sacral Neuromodulation in a Privately Insured Population." Neuromodulation: Technology at the Neural Interface 19(7): 780-784.
dc.identifier.issn1094-7159
dc.identifier.issn1525-1403
dc.identifier.urihttps://hdl.handle.net/2027.42/134200
dc.publisherWiley Periodicals, Inc.
dc.subject.otherClaims data
dc.subject.otherimplantable neurostimulators
dc.subject.othergynecology
dc.subject.otherurology
dc.subject.otherprovider volume
dc.subject.othermedical specialty
dc.titleOutcomes of Sacral Neuromodulation in a Privately Insured Population
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurology and Neurosciences
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134200/1/ner12472_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134200/2/ner12472.pdf
dc.identifier.doi10.1111/ner.12472
dc.identifier.sourceNeuromodulation: Technology at the Neural Interface
dc.identifier.citedreferenceCameron AP, Anger JT, Madison R, Saigal CS, Clemens JQ. National trends in the usage and success of sacral nerve test stimulation. J Urol 2011; 185: 970 – 975. Mar
dc.identifier.citedreferenceDougherty GJ, Dougherty ST, Kay RJ, Landsdorp P, Humphries RK. Identification and characterization of 114/A10, an antigen highly expressed on the surface of murine myeloid and erythroid progenitor cells and IL‐3‐dependent cell lines. Exp Hema Tol 1989; 17: 877 – 882.
dc.identifier.citedreferenceMirbagheri N, Sivakumaran Y, Nassar N, Gladman MA. Systematic review of the impact of sacral neuromodulation on clinical symptoms and gastrointestinal physiology. ANZ J Surg 2015;86:232–236.
dc.identifier.citedreferenceAnger JT, Rodriguez LV, Wang Q, Pashos CL, Litwin MS. The role of provider volume on outcomes after sling surgery for stress urinary incontinence. J Urol 2007; 177: 1457 – 1462.
dc.identifier.citedreferenceLeong RK, De Wachter SG, Nieman FH, de Bie RA, van Kerrebroeck PE. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn 2011; 30: 1249 – 1252.
dc.identifier.citedreferenceAmundsen CLRA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology 2005; 66: 746 – 750.
dc.identifier.citedreferenceNoblett K, Siegel S, Mangel J et al. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn 2014;35:246–251.
dc.identifier.citedreferenceAnger JT, Cameron AP, Madison R, Saigal C, Clemens JQ. Predictors of implantable pulse generator placement after sacral neuromodulation: who does better? Neuromodulation 2014; 17: 381 – 384. Jun discussion 384.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ner12472_am.pdf
Size:
269.9KB
Format:
PDF
View/Open
Name:
ner12472.pdf
Size:
89.90KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.